UTP23

gene
On this page

Also known as MGC14595

Summary

UTP23 (UTP23 small subunit processome component, HGNC:28224) is a protein-coding gene on chromosome 8q24.11, encoding rRNA-processing protein UTP23 homolog (Q9BRU9). Involved in rRNA-processing and ribosome biogenesis. It is a selective cancer dependency (DepMap: 88.3% of cell lines).

Enables mRNA 3’-UTR binding activity and mRNA 5’-UTR binding activity. Predicted to be involved in rRNA processing. Predicted to act upstream of or within endonucleolytic cleavage in 5’-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA). Predicted to be located in nucleus. Predicted to be part of small-subunit processome. Predicted to be active in nucleolus. Implicated in colorectal adenocarcinoma.

Source: NCBI Gene 84294 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 30 total
  • Cancer dependency (DepMap): dependent in 88.3% of screened cell lines
  • MANE Select transcript: NM_032334

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28224
Approved symbolUTP23
NameUTP23 small subunit processome component
Location8q24.11
Locus typegene with protein product
StatusApproved
AliasesMGC14595
Ensembl geneENSG00000147679
Ensembl biotypeprotein_coding
Entrez84294

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 5 protein_coding, 3 nonsense_mediated_decay, 2 retained_intron

ENST00000309822, ENST00000517814, ENST00000517820, ENST00000519443, ENST00000520733, ENST00000521071, ENST00000521703, ENST00000521974, ENST00000524128, ENST00000940242

RefSeq mRNA: 1 — MANE Select: NM_032334 NM_032334

CCDS: CCDS6320

Canonical transcript exons

ENST00000309822 — 3 exons

ExonStartEnd
ENSE00000981304116770192116770366
ENSE00001196281116771456116774684
ENSE00001196285116766524116766791

Expression profiles

Bgee: expression breadth ubiquitous, 260 present calls, max score 96.54.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.7004 / max 304.3934, expressed in 1786 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
9032216.70041786

Top tissues by expression

262 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
kidney epitheliumUBERON:000481996.54silver quality
pancreatic ductal cellCL:000207995.27silver quality
calcaneal tendonUBERON:000370194.94gold quality
epithelial cell of pancreasCL:000008391.76silver quality
cardia of stomachUBERON:000116291.72gold quality
pericardiumUBERON:000240791.63gold quality
layer of synovial tissueUBERON:000761691.51gold quality
corpus callosumUBERON:000233690.83gold quality
nippleUBERON:000203090.61gold quality
vena cavaUBERON:000408790.44silver quality
pylorusUBERON:000116690.37gold quality
parietal pleuraUBERON:000240090.30gold quality
tibialis anteriorUBERON:000138590.25gold quality
myocardiumUBERON:000234989.65gold quality
synovial jointUBERON:000221789.53gold quality
secondary oocyteCL:000065589.44gold quality
cardiac muscle of right atriumUBERON:000337989.39gold quality
left ventricle myocardiumUBERON:000656689.33gold quality
tendonUBERON:000004389.12gold quality
deltoidUBERON:000147688.66silver quality
mammary ductUBERON:000176588.65gold quality
superior surface of tongueUBERON:000737188.61gold quality
epithelium of mammary glandUBERON:000324488.60gold quality
visceral pleuraUBERON:000240188.49gold quality
inferior vagus X ganglionUBERON:000536388.46gold quality
oocyteCL:000002388.44gold quality
buccal mucosa cellCL:000233688.14silver quality
upper arm skinUBERON:000426388.13gold quality
nasal cavity epitheliumUBERON:000538487.75silver quality
pharyngeal mucosaUBERON:000035587.67gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-110499no1788.69
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

141 targeting UTP23, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-5692A100.0074.406850
HSA-MIR-186-5P99.9970.833707
HSA-MIR-511-3P99.9968.851467
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-477599.9875.006394
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-569699.9872.364487
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-485-3P99.9870.681585
HSA-MIR-539-3P99.9870.741616
HSA-MIR-590-3P99.9674.346478
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-426799.9666.532368
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-LET-7C-3P99.9573.422862
HSA-MIR-55999.9572.283609
HSA-MIR-548AB99.9571.313488
HSA-MIR-23A-3P99.9574.243163

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 88.3% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 5)

  • yUtp23/hUTP23 could therefore be central to the coordinated integration and release of ES6 binding factors and likely plays a pivotal role in remodeling this pre-rRNA region in both yeast and humans. Finally, studies using RNAi-rescue systems in human cells revealed that intact PIN domain and Zinc finger motifs in human hUTP23 are essential for 18S rRNA maturation. (PMID:28082392)
  • Our findings elucidated a previously unknown function for UTP23 in regulating paclitaxel sensitivity and UTP23 could serve as a potential prognostic predictor for ovarian cancer (PMID:31540773)
  • UTP23 Functions in Breast Cancer Progression and Predicts Poor Prognosis of Luminal a Breast Cancer. (PMID:37880005)
  • UTP23 Is a Promising Prognostic Biomarker and Is Associated with Immune Infiltration in Breast Cancer. (PMID:38305284)
  • Cytoplasmic expression of UTP23 promotes colorectal cancer progression. (PMID:38372088)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerioutp23ENSDARG00000105012
mus_musculusUtp23ENSMUSG00000022313
rattus_norvegicusUtp23ENSRNOG00000063314
drosophila_melanogasterCG17652FBGN0031361
caenorhabditis_elegansWBGENE00016411

Paralogs (1): FCF1 (ENSG00000119616)

Protein

Protein identifiers

rRNA-processing protein UTP23 homologQ9BRU9 (reviewed: Q9BRU9)

All UniProt accessions (7): Q9BRU9, E5RG01, E5RGP0, E5RH13, E5RIC4, E5RIM0, G3XAM4

UniProt curated annotations — full annotation on UniProt →

Function. Involved in rRNA-processing and ribosome biogenesis.

Subcellular location. Nucleus. Nucleolus.

Similarity. Belongs to the UTP23/FCF1 family. UTP23 subfamily.

Isoforms (2)

UniProt IDNamesCanonical?
Q9BRU9-11yes
Q9BRU9-22

RefSeq proteins (1): NP_115710* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR006984Fcf1/UTP23Family
IPR029060PIN-like_dom_sfHomologous_superfamily
IPR057776UTP23_sensorDomain

Pfam: PF04900, PF24779

UniProt features (12 total): sequence variant 3, compositionally biased region 2, splice variant 2, chain 1, region of interest 1, sequence conflict 1, modified residue 1, cross-link 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BRU9-F182.090.59

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 174, 179

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 90 (showing top): GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, GOBP_RIBOSOME_BIOGENESIS, GOBP_MATURATION_OF_SSU_RRNA, GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS, GOBP_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA, GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN, SENESE_HDAC1_TARGETS_UP, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOCC_PRERIBOSOME, GOCC_SMALL_SUBUNIT_PROCESSOME, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, GOCC_NUCLEOLUS, GOCC_RIBONUCLEOPROTEIN_COMPLEX, NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON, GOMF_MRNA_BINDING

GO Biological Process (3): endonucleolytic cleavage in 5’-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480), rRNA processing (GO:0006364), ribosome biogenesis (GO:0042254)

GO Molecular Function (5): RNA binding (GO:0003723), mRNA 3’-UTR binding (GO:0003730), mRNA 5’-UTR binding (GO:0048027), small ribosomal subunit rRNA binding (GO:0070181), protein binding (GO:0005515)

GO Cellular Component (3): nucleolus (GO:0005730), small-subunit processome (GO:0032040), nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
mRNA binding2
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)1
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)1
RNA processing1
rRNA metabolic process1
ribosome biogenesis1
ribonucleoprotein complex biogenesis1
nucleic acid binding1
rRNA binding1
binding1
nuclear lumen1
intracellular membraneless organelle1
nucleolus1
preribosome1
t-UTP complex1
nuclear protein-containing complex1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

1666 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
UTP23EIF3HO15372675
UTP23DDX52Q9Y2R4674
UTP23KRI1Q8N9T8648
UTP23MED30Q96HR3614
UTP23RCL1Q9Y2P8608
UTP23EMG1Q92979606
UTP23UTP3Q9NQZ2593
UTP23UTP15Q8TED0560
UTP23BMS1Q14692549
UTP23WDR46O15213535
UTP23PDCD11Q14690535
UTP23KRR1Q13601526
UTP23ABT1Q9ULW3510
UTP23RAD21O60216504
UTP23NOP14P78316490

IntAct

160 interactions, top by confidence:

ABTypeScore
KRTAP10-8UTP23psi-mi:“MI:0915”(physical association)0.720
H1-1RRP8psi-mi:“MI:0914”(association)0.640
UTP23psi-mi:“MI:0915”(physical association)0.600
UTP23psi-mi:“MI:0915”(physical association)0.600
UTP23PDE9Apsi-mi:“MI:0915”(physical association)0.560
TRIM27UTP23psi-mi:“MI:0915”(physical association)0.560
TCF4UTP23psi-mi:“MI:0915”(physical association)0.560
TRIM23UTP23psi-mi:“MI:0915”(physical association)0.560
KRTAP10-5UTP23psi-mi:“MI:0915”(physical association)0.560
KRTAP10-9UTP23psi-mi:“MI:0915”(physical association)0.560
KRT31UTP23psi-mi:“MI:0915”(physical association)0.560
KRT40UTP23psi-mi:“MI:0915”(physical association)0.560
NOTCH2NLAUTP23psi-mi:“MI:0915”(physical association)0.560
MID2UTP23psi-mi:“MI:0915”(physical association)0.560
PDE9AUTP23psi-mi:“MI:0915”(physical association)0.560
UTP23TRIM27psi-mi:“MI:0915”(physical association)0.560
UTP23TCF4psi-mi:“MI:0915”(physical association)0.560
UTP23TRIM23psi-mi:“MI:0915”(physical association)0.560
UTP23KRTAP10-5psi-mi:“MI:0915”(physical association)0.560
UTP23KRTAP10-9psi-mi:“MI:0915”(physical association)0.560

BioGRID (220): UTP23 (Two-hybrid), UTP23 (Two-hybrid), UTP23 (Two-hybrid), UTP23 (Two-hybrid), UTP23 (Two-hybrid), UTP23 (Two-hybrid), KRT40 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP10-8 (Two-hybrid), KRTAP10-3 (Two-hybrid), NOTCH2NL (Two-hybrid), UTP23 (Affinity Capture-RNA), UTP23 (Affinity Capture-MS), UTP23 (Affinity Capture-MS)

ESM2 similar proteins: A4IHS0, A5WUX7, A6ZND9, B1P1W2, B3LIY9, B4KPG8, B5XAM2, D2HD32, E7EXT2, O44568, O94443, P25642, P34511, P82673, Q05863, Q08230, Q08DT6, Q08DU1, Q09691, Q12322, Q14197, Q2KI45, Q3T116, Q3UFY8, Q497V5, Q498P2, Q5RDI0, Q5U2R4, Q60R52, Q7JUX9, Q80VP5, Q8C1Z8, Q8K2Y7, Q8MT06, Q8N5C6, Q8R035, Q8VCE1, Q95Q11, Q9BRU9, Q9BVP2

Diamond homologs: O13610, O74862, Q08DU1, Q12339, Q9BRU9, Q9CX11, Q32PD0, Q5RFQ0, Q9Y324, Q05498, Q55GM5, Q9CTH6

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 119 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Eukaryotic Translation Initiation829.8×3e-09
Cap-dependent Translation Initiation829.8×3e-09
SARS-CoV-1 modulates host translation machinery829.8×3e-09
Peptide chain elongation1929.1×3e-21
Viral mRNA Translation1929.1×3e-21
PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA1928.7×3e-21
Selenocysteine synthesis1927.5×4e-21
Eukaryotic Translation Termination1927.5×4e-21

GO biological processes:

GO termPartnersFoldFDR
cytoplasmic translation2036.7×2e-23
ribosomal small subunit biogenesis920.3×1e-07
translation1818.3×2e-15
rRNA processing1014.0×4e-07
RNA processing613.0×6e-04
regulation of alternative mRNA splicing, via spliceosome512.1×4e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

30 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance26
Likely benign0
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

459 predictions. Top by Δscore:

VariantEffectΔscore
8:116766787:ACAAG:Adonor_loss1.0000
8:116766788:CAAGG:Cdonor_loss1.0000
8:116766789:AAGG:Adonor_loss1.0000
8:116766790:AGG:Adonor_loss1.0000
8:116766791:GGT:Gdonor_loss1.0000
8:116766792:G:Adonor_loss1.0000
8:116766793:T:Gdonor_loss1.0000
8:116770186:TTTCA:Tacceptor_loss1.0000
8:116770187:TTCA:Tacceptor_loss1.0000
8:116770188:TCAG:Tacceptor_loss1.0000
8:116770189:CAGAT:Cacceptor_loss1.0000
8:116770190:A:Gacceptor_loss1.0000
8:116770191:GAT:Gacceptor_gain1.0000
8:116770191:GATGT:Gacceptor_gain1.0000
8:116770295:G:GGdonor_gain1.0000
8:116770326:TTG:Tdonor_gain1.0000
8:116770335:G:Tdonor_gain1.0000
8:116847688:CACG:Cacceptor_gain1.0000
8:116847689:ACGC:Aacceptor_loss1.0000
8:116847690:CG:Cacceptor_gain1.0000
8:116847690:CGCT:Cacceptor_loss1.0000
8:116847691:GCTG:Gacceptor_loss1.0000
8:116847692:C:CCacceptor_gain1.0000
8:116847692:CTG:Cacceptor_loss1.0000
8:116847693:T:Aacceptor_loss1.0000
8:116848947:TGAAG:Tdonor_gain1.0000
8:116766741:G:GTdonor_gain0.9900
8:116766768:G:GTdonor_gain0.9900
8:116766768:G:Tdonor_gain0.9900
8:116766778:C:Gdonor_gain0.9900

AlphaMissense

1630 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
8:116770359:C:AA119E0.999
8:116766706:T:CC35R0.998
8:116766715:G:CA38P0.997
8:116766716:C:AA38E0.997
8:116770193:T:CC64R0.997
8:116766617:G:TR5M0.996
8:116766712:G:CA37P0.996
8:116770209:T:CL69P0.996
8:116766788:C:TT62I0.995
8:116770274:T:CC91R0.995
8:116770310:T:CC103R0.995
8:116770358:G:CA119P0.995
8:116766617:G:CR5T0.994
8:116766618:G:CR5S0.994
8:116766618:G:TR5S0.994
8:116766703:T:CF34L0.994
8:116766705:C:AF34L0.994
8:116766705:C:GF34L0.994
8:116770251:C:AA83E0.994
8:116770310:T:AC103S0.994
8:116770311:G:CC103S0.994
8:116770362:C:AT120K0.994
8:116766689:T:CL29P0.993
8:116766695:A:TD31V0.993
8:116770193:T:AC64S0.993
8:116770194:G:CC64S0.993
8:116770250:G:CA83P0.993
8:116770312:T:GC103W0.993
8:116771507:T:CF139L0.993
8:116771509:T:AF139L0.993

dbSNP variants (sampled 300 via entrez): RS1000294330 (8:116765679 T>C,G), RS1001256865 (8:116773965 T>A), RS1001791055 (8:116766797 C>G,T), RS1001948125 (8:116768051 A>G), RS1002044343 (8:116774801 A>G,T), RS1003549564 (8:116772045 G>A), RS1003576642 (8:116764860 T>C), RS1003603500 (8:116772388 T>C), RS1003799729 (8:116768032 A>C), RS1004007291 (8:116774449 G>A), RS1004021088 (8:116769400 T>C), RS1004357538 (8:116774756 A>G), RS1004360879 (8:116764705 G>A,C), RS1004418574 (8:116768301 T>C), RS1004747798 (8:116769661 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

22 total (human), top 22 by PubMed support.

ChemicalActions (top 5)PubMed papers
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
dicrotophosdecreases expression1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
bisphenol Adecreases expression1
sodium arsenitedecreases expression1
di-n-butylphosphoric acidaffects expression1
pentabromodiphenyl etherdecreases expression1
jinfukangaffects cotreatment, decreases expression1
Sunitinibincreases expression1
Benzo(a)pyreneincreases methylation1
Cisplatinaffects cotreatment, decreases expression1
Doxorubicindecreases expression1
Formaldehydedecreases expression1
Ribonucleotidesaffects binding1
Smokedecreases expression1
Dronabinoldecreases expression1
Tobacco Smoke Pollutionincreases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidedecreases expression1
Asbestos, Crocidolitedecreases expression1
Cadmium Chloridedecreases expression1
Copper Sulfateincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.